DarshanTalks Podcast

Send us Fan Mail

1. Recent updates from the courts in class action lawsuits. 
2. Difference between equity and law. 
3. Demerging or diverging equity and law. 
4. Dictionaries used by courts to interpret contracts. 
5. Update on Johnson and Johnson baby powder case (Suing plaintiff’s witnesses for defamation and false advertising) 
6. Experts need to be cautious to avoid false advertising allegations against them. 
7. Update on Maybelline 24-hour make-up case. (24-hour sunscreen)  

Support the show

www.kulkarnilawfirm.com

Send us Fan Mail

Darshan explains that drugs work by either enhancing or inhibiting processes that already occur in the body. Put simply, they amplify or reduce the body's natural functions. This fundamental principle underscores how drugs interact with our biology. 

Support the show

www.kulkarnilawfirm.com

Send us Fan Mail

We discuss the five common reasons behind the failure of mergers, acquisitions and licensing deals  in the life sciences industry. 

Inadequate understanding of capability, where focusing solely on financials without comprehending the target company's regulatory and compliance processes leads to failure. 
The side project dilemma, illustrated by Philip Morris' venture into pharmaceuticals, emphasizing the importance of aligning with core business objectives. 
Clash of perspectives, exemplified by cultural and business differences between BioGene and Novartis, highlighting the necessity of alignment in strategic vision. 
Low margins on generic drugs, as seen in Teva's acquisition of Actavis, revealing the 
challenge of profitability in this sector.
Overpaying, stressing the significance of thorough due diligence to avoid paying more than a company's actual value. 

For assistance with M&A due diligence, contact us at 302-252-6959.

Support the show

www.kulkarnilawfirm.com

Send us Fan Mail

In this short, Darshan sheds light on the relationship between doctors and pharmaceutical companies. He explains how pharmaceutical companies often pay doctors to ensure they understand their drugs and promote their products. 
However, patients can now access information on what doctors are being paid by pharmaceutical companies through the CMS website, as mandated by the Sunshine Act Law. This transparency allows patients to make informed decisions about their healthcare.

Support the show

www.kulkarnilawfirm.com

Send us Fan Mail

When acquiring a drug or device company, regulatory attorneys play a crucial role in ensuring compliance during the due diligence process. It's vital to recognize that registration with state and local authorities is often overlooked by these companies, who may mistakenly believe that FDA registration suffices. However, failure to register appropriately with state and local authorities could lead to sales restrictions within those jurisdictions. Each state has its own criteria for registration, which can vary widely. Depending on the circumstances, a company may need to register as a manufacturer, distributor, or wholesaler. 

Consulting a regulatory attorney is essential to ensure proper registration and avoid potential complications down the line.

Support the show

www.kulkarnilawfirm.com

Send us Fan Mail

Have you ever wondered why your prescription takes what feels like an eternity to fill at the pharmacy? Darshan will shed some light on the process. 

When you drop off your prescription, the pharmacist isn't just mindlessly grabbing bottles from shelves. They're meticulously reviewing your medication to ensure it's the right fit for your condition, checking for potential interactions with other drugs or even your diet, and making sure it's covered by your insurance.

This detailed process, while aided by computer systems, often requires a human touch and can take some time. And remember, you're not the only one waiting for their medication – there's a queue of patients with prescriptions to fill.

So next time you're twiddling your thumbs in the pharmacy waiting area, remember that your pharmacist is doing their best to ensure your health and safety.

 

Support the show

www.kulkarnilawfirm.com

Send us Fan Mail

We cover three steps for preventing food recalls:
Identify all potential hazards.
Focus on known and foreseeable risks.
Develop preventive controls for specific hazards.
Ensure every bite is safe! Need help? Call Darshan at 302.252.6959.

Support the show

www.kulkarnilawfirm.com

Send us Fan Mail

In this video, Darshan distinguishes between dietary supplements and drugs. The 
primary difference lies in the claims they can make. Dietary supplements are treated as foods and can only make limited claims, such as improving health or well-being. In contrast, drugs undergo rigorous FDA approvals and trials to make claims of curing, treating, preventing, or mitigating diseases. While there may not be much difference chemically, the key distinction is in the level of proof required for their claims. Darshan highlights that drugs may have once been dietary supplements but must meet higher evidentiary standards. 

Support the show

www.kulkarnilawfirm.com

Send us Fan Mail

Here are 5 clinical trial record retention problems.
1. Fabricating Data and Documentation,
2. Forging the Principal Investigator's signatures,
3. Data Manipulation,
4. Misappropriating Samples and 
5. Forging Subject Dairies

Join us as we delve into the complexities of record retention and data integrity in clinical trials. Learn why compliance is key for FDA approval and how we can help. Call us at 302-252-6959 for expert assistance with your clinical trial compliance program.

Support the show

www.kulkarnilawfirm.com

Send us Fan Mail

Bringing a drug to market is a costly and intricate process, averaging $2.3 billion. This expense encompasses multiple levels of testing, ranging from small animals to extensive human trials. The drug company, whether partnering with a university or a private investor, foots the bill for each phase of testing, ensuring safety and efficacy before reaching the market. The investment covers meticulous testing procedures, safeguarding against potential risks and ensuring the drug's viability on a large scale.

Support the show

www.kulkarnilawfirm.com